New Key Statistics Module, Z-Score and F-Score
NAS:RIGL Key Ratios
Market Cap $ M | 166.71 |
Enterprise Value $ M | 177.66 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 1.38 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 120.00 |
EPS (TTM) $ | -0.11 |
Beneish M-Score | -2.6 |
10-y EBITDA Growth Rate % | 21.00 |
5-y EBITDA Growth Rate % | 22.80 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -14.49 |
EV-to-EBITDA | -16.18 |
PEG | -- |
Shares Outstanding M | 175.41 |
Net Margin (%) | -16.45 |
Operating Margin % | -12.24 |
Pre-tax Margin (%) | -16.45 |
Quick Ratio | 1.17 |
Current Ratio | 1.26 |
ROA % (ttm) | -16.51 |
ROE % (ttm) | -- |
ROIC % (ttm) | -25.92 |
Dividend Yield % | -- |
Altman Z-Score | -14.22 |
RIGL Number of Guru Trades
RIGL Volume of Guru Trades
Gurus Latest Trades with NAS:RIGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RIGL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Rigel Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:RIGL
Total 0- 1